BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21717117)

  • 1. Inhibition of T-cell responses by intratumoral hepatic stellate cells contribute to migration and invasion of hepatocellular carcinoma.
    Xia Y; Chen R; Ye SL; Sun R; Chen J; Zhao Y
    Clin Exp Metastasis; 2011 Oct; 28(7):661-74. PubMed ID: 21717117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell apoptosis induced by intratumoral activated hepatic stellate cells is associated with lung metastasis in hepatocellular carcinoma.
    Xia YH; Wang ZM; Chen RX; Ye SL; Sun RX; Xue Q; Huang Y
    Oncol Rep; 2013 Sep; 30(3):1175-84. PubMed ID: 23807027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral hepatic stellate cells as a poor prognostic marker and a new treatment target for hepatocellular carcinoma.
    Sun B; Zhang X; Cheng X; Zhang Y; Chen L; Shi L; Liu Z; Qian H; Wu M; Yin Z
    PLoS One; 2013; 8(11):e80212. PubMed ID: 24278260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice.
    Yu MC; Chen CH; Liang X; Wang L; Gandhi CR; Fung JJ; Lu L; Qian S
    Hepatology; 2004 Dec; 40(6):1312-21. PubMed ID: 15565659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice.
    Zhao W; Zhang L; Yin Z; Su W; Ren G; Zhou C; You J; Fan J; Wang X
    Int J Cancer; 2011 Dec; 129(11):2651-61. PubMed ID: 21213212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periostin involved in the activated hepatic stellate cells-induced progression of residual hepatocellular carcinoma after sublethal heat treatment: its role and potential for therapeutic inhibition.
    Zhang R; Lin XH; Ma M; Chen J; Chen J; Gao DM; Cui JF; Chen RX
    J Transl Med; 2018 Nov; 16(1):302. PubMed ID: 30400797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of hepatic stellate cells in the regulation of T-cell function and the promotion of hepatocellular carcinoma.
    Zhao W; Su W; Kuang P; Zhang L; Liu J; Yin Z; Wang X
    Int J Oncol; 2012 Aug; 41(2):457-64. PubMed ID: 22641338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat hepatic stellate cells alter the gene expression profile and promote the growth, migration and invasion of hepatocellular carcinoma cells.
    Wang ZM; Zhou LY; Liu BB; Jia QA; Dong YY; Xia YH; Ye SL
    Mol Med Rep; 2014 Oct; 10(4):1725-33. PubMed ID: 25109274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human hepatic stellate cells inhibit T-cell response through B7-H1 pathway.
    Charles R; Chou HS; Wang L; Fung JJ; Lu L; Qian S
    Transplantation; 2013 Jul; 96(1):17-24. PubMed ID: 23756770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiles during activation of cultured rat hepatic stellate cells by tumoral hepatocytes and fetal bovine serum.
    Xia Y; Chen R; Song Z; Ye S; Sun R; Xue Q; Zhang Z
    J Cancer Res Clin Oncol; 2010 Feb; 136(2):309-21. PubMed ID: 19727817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells - evidence for a role in hepatocellular carcinoma growth in vivo.
    Mußbach F; Ungefroren H; Günther B; Katenkamp K; Henklein P; Westermann M; Settmacher U; Lenk L; Sebens S; Müller JP; Böhmer FD; Kaufmann R
    Mol Cancer; 2016 Jul; 15(1):54. PubMed ID: 27473374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions.
    Wu K; Kryczek I; Chen L; Zou W; Welling TH
    Cancer Res; 2009 Oct; 69(20):8067-75. PubMed ID: 19826049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatic stellate cells inhibit the proliferation and invasion of HepG2 hepatocellular carcinoma via activating γδ T cells].
    Fan K; Liao R; Xie Y; Peng C; Du C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Jul; 33(7):870-874. PubMed ID: 28712391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCN1/Cyr61 enhances the function of hepatic stellate cells in promoting the progression of hepatocellular carcinoma.
    Li ZQ; Wu WR; Zhao C; Zhao C; Zhang XL; Yang Z; Pan J; Si WK
    Int J Mol Med; 2018 Mar; 41(3):1518-1528. PubMed ID: 29286082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma.
    Liao X; Bu Y; Chang F; Jia F; Song G; Xiao X; Zhang M; Ning P; Jia Q
    BMC Cancer; 2019 Dec; 19(1):1192. PubMed ID: 31805888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herbal compound "Songyou Yin" attenuates hepatoma cell invasiveness and metastasis through downregulation of cytokines secreted by activated hepatic stellate cells.
    Jia QA; Wang ZM; Ren ZG; Bu Y; Xie XY; Wang YH; Zhang L; Zhang QB; Xue TC; Deng LF; Tang ZY
    BMC Complement Altern Med; 2013 Apr; 13():89. PubMed ID: 23622143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated hepatic stellate cells promote hepatocellular carcinoma cell migration and invasion via the activation of FAK-MMP9 signaling.
    Han S; Han L; Yao Y; Sun H; Zan X; Liu Q
    Oncol Rep; 2014 Feb; 31(2):641-8. PubMed ID: 24284889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of differential gene expression in rat hepatic stellate cells activated by culture or hepatocellular carcinoma cell induction].
    Xia YH; Song ZJ; Chen RX; Ye SL; Sun RX; Xue Q
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):164-9. PubMed ID: 19615251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma.
    Xie YX; Liao R; Pan L; Du CY
    Immunol Lett; 2017 Aug; 188():116-123. PubMed ID: 28668554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-17-educated monocytes suppress cytotoxic T-cell function through B7-H1 in hepatocellular carcinoma patients.
    Zhao Q; Xiao X; Wu Y; Wei Y; Zhu LY; Zhou J; Kuang DM
    Eur J Immunol; 2011 Aug; 41(8):2314-22. PubMed ID: 21674477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.